Search Results - "Combe, B"

Chikungunya Virus-Associated Disease by Hua, C., Combe, B.

“…Purpose of Review Chikungunya virus (CHIKV) infection has become increasingly prevalent in the last decade not only across the southern hemisphere but also,…”
Get full text

Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis by Szafors, P., Che, H., Barnetche, T., Morel, J., Gaujoux-Viala, C., Combe, B., Lukas, C.

“…Inflammatory bowel diseases (IBDs) are associated with a decreased bone mineral density, but the impact on fractures is unknown. In our study, global risk of…”
Get full text

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) by Combe, B, Landewe, R, Lukas, C, Bolosiu, H D, Breedveld, F, Dougados, M, Emery, P, Ferraccioli, G, Hazes, J M W, Klareskog, L, Machold, K, Martin-Mola, E, Nielsen, H, Silman, A, Smolen, J, Yazici, H

“…Objective: To formulate EULAR recommendations for the management of early arthritis. Methods: In accordance with EULAR’s “standardised operating procedures”,…”
Get full text

Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases by Bouquillard, E, Combe, B

Get more information

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)) by Emery, P, Deodhar, A, Rigby, W F, Isaacs, J D, Combe, B, Racewicz, A J, Latinis, K, Abud-Mendoza, C, Szczepanski, L J, Roschmann, R A, Chen, A, Armstrong, G K, Douglass, W, Tyrrell, H

“…This phase III study evaluated the efficacy and safety of rituximab plus methotrexate (MTX) in patients with active rheumatoid arthritis (RA) who had an…”
Get more information

Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort by Combe, B, Logeart, I, Belkacemi, M C, Dadoun, S, Schaeverbeke, T, Daurès, J P, Dougados, M

“…To investigate if patients with early RA with persistent moderate disease activity during the first year after diagnosis have a worse 3-5 year outcome than…”
Get more information

Benefit and management of biologics in patients with chronic inflammatory by Combe, B., Prof

“…Rheumatoid arthritis (RA) and Spondyloarthritis (SpA) control and outcome have greatly improved with the efficacy of biologic disease-modifying anti-rheumatic…”
Get full text

Disease-modifying drug retention rate according to patient age in patients with early rheumatoid arthritis: analysis of the ESPOIR cohort by Mathieu, S., Pereira, B., Saraux, A., Richez, C., Combe, B., Soubrier, M.

“…Physicians are sometimes hesitant to use disease-modifying antirheumatic drugs (DMARDs) in elderly patients with rheumatoid arthritis (RA), as they are deemed…”
Get full text

Tumour necrosis factor α blocking agents in refractory adult Still’s disease: an observational study of 20 cases by Fautrel, B, Sibilia, J, Mariette, X, Combe, B

“…Background: Consensus is lacking on treatment for corticosteroid resistant adult onset Still’s disease (ASD). Objective: To assess anti-TNFα efficacy and…”
Get full text

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients by Rauwel, B, Degboé, Y, Nigon, D, Boyer, J-F, Abravanel, F, Izopet, J, Combe, B, Ruyssen-Witrand, A, Constantin, A, Cantagrel, A, Davignon, J-L

“…Human cytomegalovirus (HCMV) seropositivity has been associated with higher inflammation during rheumatoid arthritis (RA). However, no data are available on…”
Get full text

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry by Gottenberg, J E, Ravaud, P, Cantagrel, A, Combe, B, Flipo, R M, Schaeverbeke, T, Houvenagel, E, Gaudin, P, Loeuille, D, Rist, S, Dougados, M, Sibilia, J, Le Loët, X, Marcelli, C, Bardin, T, Pane, I, Baron, G, Mariette, X

“…Very limited data are available regarding the efficacy of abatacept (ABA) in real life. The aims of this study were to determine the efficacy of ABA in…”
Get more information

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry by Terrier, B., Launay, D., Kaplanski, G., Hot, A., Larroche, C., Cathébras, P., Combe, B., de Jaureguiberry, J. P., Meyer, O., Schaeverbeke, T., Somogyi, A., Tricot, L., Zénone, T., Ravaud, P., Gottenberg, J. E., Mariette, X., Cacoub, P.

“…Objective Management of nonviral cryoglobulinemia vasculitis has yet to be defined. Rituximab has emerged as a novel and promising therapeutic alternative, but…”
Get full text

Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort by Rodríguez-Muguruza, S, Combe, B, Guillemin, F, Fautrel, B, Olive, A, Marsal, S, Valero, O, Rincheval, N, Lukas, C

“…To determine, in a cohort of patients with early rheumatoid arthritis (RA), factors associated with fatigue at baseline, describe its evolution over 5 years of…”
Get full text

Tumour necrosis factor   blocking agents in refractory adult Still's disease: an observational study of 20 cases by Fautrel, B

“…Background: Consensus is lacking on treatment for corticosteroid resistant adult onset Still's disease (ASD). Objective: To assess anti-TNFα efficacy and…”
Get full text

Favorable effect of very early disease‐modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des Polyarthrites IndifféRenciées récentes (Study and Followup of Early Undifferentiated Polyarthritis) by Lukas, C., Combe, B., Ravaud, P., Sibilia, J., Landew, R., van der Heijde, D.

“…Objective While there is consensus that treatment with disease‐modifying antirheumatic drugs (DMARDs) should be started early in patients with inflammatory…”
Get full text

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab by Ruyssen-Witrand, A, Rouanet, S, Combe, B, Dougados, M, Le Loët, X, Sibilia, J, Tebib, J, Mariette, X, Constantin, A

“…To assess the association between a single nucleotide polymorphism in the gene of FCGR3A and the response to treatment with rituximab (RTX) in rheumatoid…”
Get more information

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE) by Dougados, M, Braun, J, Szanto, S, Combe, B, Elbaz, M, Geher, P, Thabut, G, Leblanc, V, Logeart, I

“…Patients with advanced ankylosing spondylitis (AS) experience disability because of reduced spinal mobility and pulmonary function impairment. This…”
Get more information

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry by Salmon, J H, Gottenberg, J E, Ravaud, P, Cantagrel, A, Combe, B, Flipo, R M, Schaeverbeke, T, Houvenagel, E, Gaudin, P, Loeuille, D, Rist, S, Dougados, M, Sibilia, J, Le Loët, X, Meyer, O, Solau-Gervais, E, Marcelli, C, Bardin, T, Pane, I, Baron, G, Perrodeau, E, Mariette, X

“…Little data are available regarding the rate and predicting factors of serious infections in patients with rheumatoid arthritis (RA) treated with abatacept…”
Get more information

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage by Meyer, O, Labarre, C, Dougados, M, Goupille, Ph, Cantagrel, A, Dubois, A, Nicaise-Roland, P, Sibilia, J, Combe, B

“…Objective: To study the value of antibodies to citrullinated proteins/peptides for predicting joint outcomes in patients with recent onset rheumatoid arthritis…”
Get full text

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search by Schoels, Monika, Knevel, Rachel, Aletaha, Daniel, Bijlsma, Johannes W J, Breedveld, Ferdinand C, Boumpas, Dimitrios T, Burmester, Gerd, Combe, Bernard, Cutolo, Maurizio, Dougados, Maxime, Emery, Paul, van der Heijde, Desirée, Huizinga, Tom W J, Kalden, Joachim, Keystone, Edward C, Kvien, Tore K, Martin-Mola, Emilio, Montecucco, Carlomaurizio, de Wit, Maarten, Smolen, Josef S

“…To summarise existing evidence on a target oriented approach for rheumatoid arthritis (RA) treatment. We conducted a systematic literature search including all…”
Get more information